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A global perspective on the influence of
environmental exposures on the nervous system
Desire Tshala-Katumbay1,2,3, Jean-Claude Mwanza4, Diane S. Rohlman5,6, Gladys Maestre7 & Reinaldo B. Oriá8

Economic transitions in the era of globalization warrant a fresh look at the neurological risks associated with environmental
change. These are driven by industrial expansion, transfer and mobility of goods, climate change and population growth. In these
contexts, risk of infectious and non-infectious diseases are shared across geographical boundaries. In low- and middle-income
countries, the risk of environmentally mediated brain disease is augmented several fold by lack of infrastructure, poor health and
safety regulations, and limited measures for environmental protection. Neurological disorders may occur as a result of direct
exposure to chemical and/or non-chemical stressors, including but not limited to, ultrafine particulate matters. Individual susceptibilities to exposure-related diseases are modified by genetic, epigenetic and metagenomic factors. The existence of several
uniquely exposed populations, including those in the areas surrounding the Niger Delta or north western Amazon oil operations;
those working in poorly regulated environments, such as artisanal mining industries; or those, mostly in sub-Saharan Africa, relying on cassava as a staple food, offers invaluable opportunities to advance the current understanding of brain responses to environmental challenges. Increased awareness of the brain disorders that are prevalent in low- and middle-income countries and
investments in capacity for further environmental health-related research are positive steps towards improving human health.
Nature 527, S187-S192 (19 November 2015), DOI: 10.1038/nature16034
This article has not been written or reviewed by Nature editors. Nature accepts no responsibility for the accuracy of the information provided.

R

eports from the World Health Organization (WHO) indicate that
the global burden of disease is determined by patterns of disease
and disability in low- and middle-income countries (LMICs),
which, predictably, have their own environmental signatures (http://
www.who.int/healthinfo/global_burden_disease/about/en/). However, the effect of such signatures on both brain health and region or
global disability-adjusted life years (DALYs) remains unknown and
needs to be added to the agenda of global environmental health research. As for high-income countries, environmental health research
programmes in LMICs must primarily focus on elucidating the entire
range and source of exposures to define the human ‘exposome’ (the
measure of all the exposures of an individual in their lifetime and how
these exposures relate to health) relevant to brain health in LMICs. The
research agenda should also include mechanistic and translational research, as well as capacity building to foster a new generation of environmental health scientists.

SCOPE
In this Review, we focus on environmental risk factors for brain diseases
and conditions in LMICs (http://data.worldbank.org/about/countryand-lending-groups). An iterative search of the literature was conducted using PubMed to retrieve information related to environmental
determinants and mechanisms of brain disease in LMICs. Additional
opinion was obtained from interviews with leading environmental

scientists and neuroscientists, as well as programme officers at the US
National Institutes of Health and US National Institute of Environmental Health Sciences (NIEHS), and Fogarty International Center. This
Review integrates the goals and approaches to environmental health
research as per the NIEHS 2012–2017 strategic plan (https://www.
niehs.nih.gov/about/strategicplan/).

ENVIRONMENTAL EXPOSURE AND BRAIN HEALTH
LMICs are home to around 80–85% of the world’s population1. Of these
5.8 billion people2, 1 billion remain in extreme poverty, living below the
US$1.25 per day poverty line3. Around 3 billion people do not have piped
drinking water in their home and 173 million people rely on the direct
use of surface water. Without proper sanitation, about one billion continue to defecate in gutters, in the open bush or in open water bodies4.
Wildfires and deforestation are commonplace and drought and floods,
possibly due to climate change, degrade the existing farming systems
and create food insecurity5–7. Armed conflicts and population displacements impose a toll on human life8. Industrial expansion coexists with
an unprecedented rise in artisanal mining and unprotected labour9.
In some instances, normal urbanization operations, such as road construction and quarantines (for example during Ebola outbreaks in the
Democratic Republic of the Congo) have created conditions that exacerbated the risk of environmental exposure and brain disease10. Flawed
regulations compounded by a lack of infrastructure set the stage for
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Table 1 | Heavy metals and exposure-related outcomes
Heavy metal

Source of exposure

Susceptibility window

Neurological outcomes

Proposed mechanisms

Lead76–78

Lead-contaminated dust, lead-based
paint, soil, drinking water, air, leaded
gasoline, toys and lead-contaminated
sweets

Lifelong

Visual and verbal memory decline,
intellectual deficits, decline in
executive functioning (fine motor
function, hand-eye coordination and
reaction time) and hyperactivity in
children

Disruption of neurotransmitter
release and function, and prenatal
disruption of neuronal migration and
differentiation; aggravating factors
include poor nutrition (deficiency in
iron, zinc and calcium) and younger
age

Mercury79,80

Mining industry, power plants,
crematoria, charcoal industry, and
contaminated food (mostly sea food)
and water

From neural development to
neurulation, and adolescence

Ataxia in adults and language,
attention, and visuospatial
performance deficits in children

Oxidative stress or impairment of
intracellular calcium and glutamate
homeostasis

Arsenic80,81

Contaminated food and drinking
water, air and arsenic-based
treatments

5–15 years

Impaired selective and focused
attention and long-term memory
in children, and sensorimotor
polyneuropathy

Oxidative stress or disruption of
metabolism of neurotransmitters

Copper82

Contaminated drinking water and
food, uncoated copper cookware and
infant formula containing copper

Children
Those over 65

Alzheimer’s disease, OCD, ADHD,
antisocial behaviour and anxiety in
children

Oxidative stress, microglia
cell activation or promotion of
α-synuclein and fibril formation

Cobalt82,83

Contaminated drinking water and
food, inhalation of dust containing
cobalt particles in various industries

Prenatal, young children and the
elderly

Optic, auditory and peripheral
neuropathy, motor deficits and verbal
memory loss

Alteration of mitochondrial oxidative
phosphorylation or depletion of
neurotransmitters

Cadmium83

Fumes or dust, cigarette smoke, and
contaminated food and water

Prenatal, young children and the
elderly

Antisocial behaviour and attention
impairment in children, parkinsonism
and peripheral neuropathy

Oxidative damage and
neurotransmitter disruption

Manganese76,79

Airborne as fumes, aerosols or
suspended particulate matter and
contaminated water

Childhood and the elderly

Reduced IQ, impaired verbal learning
and working and immediate memory
in children, and Parkinson-like
symptoms

Disruption of mitochondrial
respiratory chain reaction;
aggravating factors include iron
deficiency and impaired biliary
excretion (liver injury or disease)

Aluminium84

Contaminated air, water and food,
cosmetics (such as antiperspirants),
metal industries and pharmaceuticals

Lifelong

Alzheimer’s pathology in the form of
neurofibrillary tangles

Disruption of mitochondrial
respiratory chain reaction or
inflammation; zinc deficiency
acknowledged as an aggravating
factor

ADHD, attention-deficit hyperactivity disorder; OCD, obsessive compulsive disorder.

environmental degradation and pollution to pose serious threats — of a
chemical or non-chemical nature — to human health. The degradation
of local ecosystems leads to the creation of ‘microenvironments’ that
have a high risk of harmful exposures, often resulting in unique challenges and increased risk of human disease (Fig. 1).

HIGH-RISK POPULATIONS AND MICROENVIRONMENTS
Risk of exposure-related brain disease is determined by age, gender
and microenvironments created by natural disasters in which economic, social and cultural determinants of health often have important roles. One example of a profit-mediated environmental risk is that
caused by the oil industry through accidental spills or mismanagement
of oil operations. For instance, crude oil operations have polluted large
areas of rainforests, including streams and rivers in Ecuador, Peru
and Colombia11. The population of Nigeria has faced similar challenges
owing to reoccurring oil spills as a result of ageing, ill-maintained or
sabotaged pipelines in the Niger Delta. The impact of such man-made
and preventable natural disasters on human health has yet to be determined. Effects on human health will depend on the type and composition of the spilled oils, which often contain a mixture of polycyclic hydrocarbons that are known to be toxic to the nervous system11. Oil spills
arise owing to reasons, such as a lack of vigilance, neglect of necessary
health and safety checks, or sometimes even promotion of commercial
interests at the expense of communities. Symptoms of acute exposure
to raw oil include consistent episodes of headache, nausea, dizziness
and fatigue. Chronic effects include psychological disorders, endocrine
abnormalities and genotoxic effects12.
Microenvironments in which the population has a higher susceptibility to exposure-related diseases have also been created by extreme
poverty and natural disasters, including drought and flooding that can
degrade soils, plants and farming operations. The burden of conventional neurodevelopmental stressors (for example, lead) on children
is exacerbated by unique environmental challenges, including malnutrition and enteric infections13–16 and, possibly, a diet of neurotoxicant-containing plants such as cassava (Manihot esculenta; also known
S188

as tapioca), the grass pea Lathyrus sativus or the seeds from the cycad
plants, which are all known to be associated with a high burden of neurodisabilities at a population level17–22. Populations with unique exposures and risks include those living in the tropical cassava belt of Angola, the Central African Republic, Cameroon, Congo, Tanzania, Uganda,
Nigeria and Mozambique23–30; those reliant on L. sativus as a staple food
in Ethiopia, Eritrea, India and Bangladesh20,31–33; and the people of the
Pacific island Guam or the Japanese Kii Peninsula where the rates of
environmentally linked syndromes such as amyotrophic lateral sclerosis-parkinsonism-dementia complex (ALS/PDC) have been declining
for reasons that have yet to be uncovered34,35.
The impact of early childhood diseases that lead to a vicious cycle of
enteric infections and malnutrition has been underestimated and neglected, especially in areas that lack acceptable levels of hygiene and
sanitation and that have reduced accessibility to vaccines and antimicrobials. This has caused clinically silent, chronic-illness-related effects, which jeopardize the child’s full cognitive development13,15. This
vicious cycle establishes what is called environmental enteropathy, a
mostly subclinical condition (even without diarrhoea) caused by various degrees of intestinal barrier dysfunction, luminal-to-blood intestinal bacterial translocation, low-grade local and systemic inflammation, and disrupted innate intestinal immune responses that may
affect growth36 and cognition37 and possibly lead to neurodegeneration
as well as liver, and metabolic diseases later in life38,39.
Adolescents in LMICs experience a higher burden of exposures (in
contrast with those in high-income countries), primarily because of
the childhood labour crisis. Although there are regulations and international agreements restricting child labour, often there are exceptions
for certain industries, notably the growing agricultural industry, one
of the most hazardous industries worldwide40,41. In this context, adolescent workers are at risk of exposure to agrochemicals such as pesticides42,43. Other work-related threats include exposure to organic solvents in work that involves painting and manufacture, to toxic metals
and fine particulate matters in artisanal mining, and to heat and ambient air pollution while working long hours and outside41. Exposure to
19 November 2015 | 7578 | 527
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Table 2 | Organic compounds and exposure-related outcomes
Organic compound

Source of exposure

Susceptibility window

Neurological outcomes

Proposed mechanisms

Bisphenol A85,86

Food from cans with linings that
contain BPA, and contaminated food
and water

Prenatal and childhood

Anxious behaviour, hyperactivity and
depressive behaviour, and learning
impairment in children

Unclear, but females seem to be more
susceptible

Phthalates86–88

Food or drink that has been in
contact with containers or products
containing phthalates, and air and
dust containing phthalates

Prenatal and childhood

Depressive and conduct-related
behaviours (ODD, attention
problems, rule-breaking and
aggressive behaviour in children)

Oxidative stress

Organophosphates89,90

Contaminated food and water,
polluted air and professional dermal
contact

Lifelong

Neurodevelopmental deficits,
impaired attention and working
memory, impaired speed and
executive functions, and delayed
peripheral polyneuropathy

Inhibition of acetyl-cholinesterase

Organochlorinated compounds
(DDT/PCBs)91

Contaminated food, drinking water
and air

Prenatal and lifelong

Impaired intellectual ability, ADHDlike behaviours and locomotor
deficits

Disruption of neurotransmitter
function, oxidative stress
or derangement of calcium
homeostasis; children seem to be
more susceptible.

Organobromide compounds
(PBDEs)92,93

Contaminated food, water and air

Lifelong

IQ deficits, impaired attention, fine
motor coordination and cognition
functioning in children

Impairment of thyroid hormone
homeostasis

Organic solvents94,95

Air and professional dermal contact
and glue sniffing

Adolescence and adulthood

Headache, memory deficits, and
central and peripheral neuropathy

Protein adduction and/or oxidative
misfolding or oxidative stress

Food-born neurotoxicants
(cassava cyanogenic glucosides
and BOAA in Lathyrus
sativus)96–98 or contaminants
(fungal toxins)

Oral ingestion

Lifelong

Spastic paraparesis, cognition deficits
and possibly convulsive disorders

Oxidative stress, excitotoxicity and
protein carbamylation for cassava
cyanogens; children and females
seem to be more susceptible;
malnutrition is acknowledged as an
aggravating factor

ADHD, attention-deficit hyperactivity disorder; BOAA, beta-(n)-oxalyl-amino-l-alanine acid; BPA, bisphenol A; DDT/PCBs, dichlorodiphenyltrichloroethane/polychlorinated biphenols; ODD, oppositional
defiant disorder.

Table 3 | Complex exposures and neurological outcomes
Exposure

Source of exposure

Susceptibility window

Neurological outcomes

Proposed mechanisms

Coal/charcoal burning99,100

Charcoal/coal combustion, gas
grilling, wood smoke, or coal mine
dust or ash

Lifelong

Neurological signs of exposure to
arsenic

Oxidative stress

Car emissions101,102

Contaminated air

Lifelong

Learning disability and motor
impairment

Oxidative stress or neurotransmission
disruption

Fine and ultrafine particulate
matters103

Air pollution from car or construction
equipment exhausts, wood burning,
heating oil or coal, forest fires,
volcanic eruptions, tobacco smoke
and cooking

Lifelong

Behavioural and decreased IQ,
impaired fluid cognition, memory
and executive functions, and possibly
autism

Oxidative stress, neurotransmission
disruption or neuroinflammation

industrial solvents such as n-hexane, for example, may occur because
of poor safety regulations or recreational glue sniffing. This may result
in headache, acute encephalopathy or sensorimotor neuropathies that
are reversible on cessation44.
Adults in LMICs may be at a particularly high risk of environmental
exposure and related brain diseases compared with those in high-income countries. In general, they experience a higher burden of disease
owing to a lifetime of cumulative exposures and co-morbidities that are
highly prevalent in LMICs. The latter include malaria, nutritional deficiencies and neurotropic infections such as those caused by human
T-cell lymphotropic viruses (HTLV). For example, it was reported that
endemic foci of HTLV-I-associated myelopathy coexist with outbreaks
of konzo (a spastic paraparesis linked to the toxicity of cassava cyanogens) in some regions of the Congo45,46. In these areas, women of childbearing age are particularly susceptible to the toxicity of cassava cyanogens for reasons that have not been elucidated, although they may be
linked to hormonal influences and poor nutrition47.

PATHWAYS TO BRAIN DISEASE
Exposure-related brain damage may result from chemical and/or
non-chemical stressors. Damage to the nervous system often leads
to a range of bilateral and symmetrical motor and/or sensory symptoms. Behavioural problems, cognition deficits and psychiatric illness
may also occur. Non-chemical stressors include, but are not limited to,
psychological stress, heat, noise, fine and ultrafine particulate matter
(FUPM), and waterborne, airborne or foodborne pathogens that may
527 | 7578 | 19 November 2015

occur under the conceptual framework shown in Fig. 1. Chemicals with
neurotoxic potential that people are commonly exposed to are listed
in Tables 1–3. Mixed exposure, for example chemical-covered FUPM
from industrial emissions; co-exposure to chemical and non-chemical stressors; and repeated and multiple exposure can occur, creating a
complex human environmental exposome.
Brain damage linked to chemical exposure may result from chemicals interfering with neurotransmission through molecular mimicry
or reacting with crucial biomolecules and causing incorrect function
(for example, protein or DNA adduction and/or crosslinking). For
both chemical and non-chemical exposures, the mechanisms of brain
damage may include injury to the vascular system (for example, fine
particulate matter induced vascular pathology), systemic dyshomeostasis (for example, cadmium-induced kidney disease) and hormonal
imbalance (for example, through endocrine disruption; Table 1).
The susceptibility to exposure-related disease is, however, determined by mechanisms of functional genetics, epigenetics and
metagenomics at the interface between risk factors and neurological
outcomes (Fig. 2).
It is increasingly acknowledged that genetic and epigenetic factors,
including the effect of maternal stress on brain function, influence the
effect of environmental exposure48,49. For example, the E4 allele of the
APOE gene that is reportedly associated with higher risk of late-onset
Alzheimer’s disease, although not in people from sub-Saharan Africa
and with a mild association among Hispanic people, is associated with
protection against early childhood diarrhoea and its related cognitive
S189
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Figure 1 | Environmental (chemical and non-chemical) threats to brain health in low- and middle-income countries. Multiple sources of exposure (air, water and
food) coexist, and malnutrition and vector-borne diseases, notably infections, compound the risk of brain disease. Co-exposures not shown include heat, psychological stress and a poor physical environment, such as crowding.
impairment50–52. One example of gene–environment interactions is the
relationship between air pollution components and the gene encoding the MET receptor tyrosine kinase. Several studies have implicated
MET as an autism risk gene53–55. Stratification of the risk conferred by a
functional promoter variant in this gene (rs1858830) and by local traffic-related air pollution (regional particulate matter less than 10 micrometres in diameter and nitrogen dioxide exposure) revealed significant multiplicative interaction between the risk genotype and the air
pollution exposure56.
Our knowledge of the pathways that lead to late onset of exposure-related neurological disease is still sparse57,58. Many studies suggest that the genetic and environmental causes of late onset diseases
act in parallel and share common molecular mechanisms59. A number
of studies have supported the concept that early-life exposure to pollutants reprograms global gene expression in old age through epigenetic mechanisms60–63. Variation in exposure response, even among
individuals exposed to the same environment could be due not only
to early-life exposures, but also to differences in genetic make up64–66.
The extent and nature of exposures and related brain diseases in LMICs
provide opportunities to explore and overcome the long reach that
childhood exposure has into adulthood, as well as provide us with new
advances in environmental health sciences67.
Exposure-related neurological deficits in LMICs range from peripheral neuropathies to a large number of acute, subacute or chronic central nervous system diseases. Deficits may occur prenatally, or
during childhood or adolescence, and may be carried through to old
age. Clinical implications include, but are not limited to, neural tube
defects, learning disabilities, behavioural problems, psychiatric disorders, cognitive decline and the occurrence of distinct entities such
as neurolathyrism, tropical ataxic neuropathy, ALS/PDC and konzo20,30,35,68,69 (Fig. 3).
The human microbiome may be of particular interest to the mechanistic understanding of exposure-related diseases in LMICs because it
may influence the burden of heavy metals70, the metabolism of foodborne neurotoxicants such as cassava cyanogens18, and the outcome of
enteric diseases in early life, including the child’s neurodevelopmental
potential71–73.

RESEARCH AND CAPACITY BUILDING
Recent advances in environmental health sciences have elucidated the myriad risk factors and mechanisms of brain damage that are
S190

associated with environmental exposures. The existence of uniquely
exposed populations in LMICs offers invaluable opportunities to advance our current understanding of brain responses to environmental
threats. In some instances, well-characterized neurotoxicants may be
used as chemical probes to dissect the pathophysiology of the nervous system. However, challenges at the population level still remain,
including setting exposure limits and developing metrics and methodologies to assess the long-term impact of environmental exposures
on disease burden in LMICs and, therefore, globally. Climate change
and mining of rare elements, which may include radioactive materials,
present unpredictable risks, and should be added to the environmental
health research agenda. The toll of such exposures on the global burden of disease may be efficiently addressed only through competent
partnerships and alliances established on a global scale and focused on
key areas and priorities (Box 1). Although there is evidence that some
of these are already in place, more research and research capacity is
needed to continue this agenda to improve human health, globally.

ONE HEALTH–GLOBAL HEALTH DIMENSIONS
Environmental degradation and contamination, changes in climate and
ecosystems, and vector-born pathogens or neurotoxicants are the primary environmental threats to human life and intellectual performance.

BOX 1 | INTERWOVEN RESEARCH AREAS AND INVESTMENT PRIORITIES IN GLOBAL ENVIRONMENTAL RESEARCH
• Epidemiology and statistical modelling for exposure and risk
assessment in co-exposure and co-morbidity scenarios
• High-throughput ‘-omic’ methodologies
• Bioinformatics and knowledge management
• Development of diagnostic and remediation tools — validation
and implementation of environmental sensors, detectors and
biomonitors of exposure and related outcomes
• Development of metrics and methodologies to assess the longterm impact of environmental exposures on neurological disease
burden
• Understanding the pathways that lead to late onset of exposurerelated neurological diseases
• Training and capacity building in the areas listed above

19 November 2015 | 7578 | 527
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Figure 2 | Environmental framework and pathways to environmentally induced
neurological disease in low- and middle-income countries. Susceptibility to
neurological disease is determined at the interface between a particular exposure, epigenetic and metagenetic make up, and the presence of co-morbidities.

Figure 3 | Neurocognition deficits in konzo, a disease linked to eating cyanogenic cassava. a, Spasticity in a 14-year old boy severely affected by konzo. b,
Deficits in mental processing are evident from the results of a neuropsychological test.

Humans, plants and animals adapt to environmental challenges, but
some may overcome their adaptive capabilities and create imminent
risks for all17,74. Strategies to promote human health will therefore require a serious commitment to trans-disciplinary work, plant and animal health and building capacity on a global scale75.
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